Underhill Investment Management Has Decreased Its Air Lease Cl A (AL) Stake; 4 Analysts Are Bullish Cogentix Medical, Inc. (CGNT) Last Week

February 18, 2018 - By Dolores Ford

Among 4 analysts covering Cogentix Medical (NASDAQ:CGNT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cogentix Medical had 8 analyst reports since November 5, 2015 according to SRatingsIntel. The stock of Cogentix Medical, Inc. (NASDAQ:CGNT) has “Buy” rating given on Wednesday, November 8 by Roth Capital. Roth Capital maintained the stock with “Buy” rating in Wednesday, August 2 report. The rating was upgraded by TH Capital on Thursday, November 5 to “Buy”. JMP Securities initiated it with “Buy” rating and $5.0 target in Friday, October 6 report. The rating was downgraded by Roth Capital to “Neutral” on Friday, May 6. The firm earned “Buy” rating on Thursday, November 5 by Roth Capital. Roth Capital maintained Cogentix Medical, Inc. (NASDAQ:CGNT) rating on Tuesday, July 18. Roth Capital has “Buy” rating and $2.3000 target. See Cogentix Medical, Inc. (NASDAQ:CGNT) latest ratings:

01/12/2017 Broker: Aegis Capital Rating: Buy New Target: $4.75 Initiates Coverage On
08/11/2017 Broker: Roth Capital Old Rating: Buy New Rating: Buy New Target: $4 Maintain
06/10/2017 Broker: JMP Securities Rating: Buy New Target: $5.0 Initiate

Underhill Investment Management Llc decreased Air Lease Corp Cl A (AL) stake by 4.06% reported in 2017Q3 SEC filing. Underhill Investment Management Llc sold 18,350 shares as Air Lease Corp Cl A (AL)’s stock declined 4.16%. The Underhill Investment Management Llc holds 433,950 shares with $18.50M value, down from 452,300 last quarter. Air Lease Corp Cl A now has $4.76B valuation. The stock increased 0.41% or $0.19 during the last trading session, reaching $46.06. About 444,195 shares traded. Air Lease Corporation (NYSE:AL) has risen 29.12% since February 18, 2017 and is uptrending. It has outperformed by 12.42% the S&P500.

The stock increased 1.41% or $0.04 during the last trading session, reaching $2.88. About 135,978 shares traded or 90.29% up from the average. Cogentix Medical, Inc. (NASDAQ:CGNT) has risen 83.33% since February 18, 2017 and is uptrending. It has outperformed by 66.63% the S&P500.

Cogentix Medical, Inc., a medical device company, designs, develops, makes, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company has market cap of $175.41 million. The firm offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use. It currently has negative earnings. It also provides EndoSheath Protective Barrier, a sterile, single-use microbial barrier for use with flexible endoscopes.

Analysts await Air Lease Corporation (NYSE:AL) to report earnings on February, 22. They expect $0.88 earnings per share, down 38.89% or $0.56 from last year’s $1.44 per share. AL’s profit will be $90.85M for 13.09 P/E if the $0.88 EPS becomes a reality. After $0.90 actual earnings per share reported by Air Lease Corporation for the previous quarter, Wall Street now forecasts -2.22% negative EPS growth.

Since August 23, 2017, it had 0 insider purchases, and 7 sales for $3.64 million activity. Another trade for 52,000 shares valued at $2.34M was sold by Chen Jie. Khatibi Alex A sold $440,000 worth of stock or 11,000 shares. Another trade for 2,000 shares valued at $89,980 was sold by Korde Kishore. Baer Marc H had sold 7,562 shares worth $300,346.

Among 13 analysts covering Air Lease (NYSE:AL), 9 have Buy rating, 1 Sell and 3 Hold. Therefore 69% are positive. Air Lease had 40 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, September 29, the company rating was maintained by RBC Capital Markets. The firm has “Outperform” rating given on Friday, May 5 by FBR Capital. On Monday, January 8 the stock rating was maintained by RBC Capital Markets with “Buy”. RBC Capital Markets maintained Air Lease Corporation (NYSE:AL) on Friday, November 6 with “Top Pick” rating. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, July 5 report. On Tuesday, November 22 the stock rating was maintained by FBR Capital with “Outperform”. On Monday, July 10 the stock rating was maintained by Cowen & Co with “Buy”. Cowen & Co maintained it with “Buy” rating and $45.0 target in Tuesday, September 5 report. On Tuesday, October 13 the stock rating was reinitiated by FBR Capital with “Outperform”. The firm earned “Hold” rating on Friday, December 8 by Citigroup.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Dolores Ford

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: